Alnylam Pharmaceuticals



Ebit تغيير تاريخ
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 3.6B 434M 2025-03
Arrowhead Research USD -161412000 791K 2024-12
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Incyte USD 283.64M 92.62M 2025-03
Ionis Pharmaceuticals USD -146000000 36M 2025-03
Moderna USD -963000000 283M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
PTC Therapeutics USD -162389000 107.88M 2024-12
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Sanofi EUR 2.22B 2.84B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Takeda JPY 58B 129.82B 2024-12
Tectonic Therapeutic USD -13989000 5.65M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12
Xencor USD -13178000 47.7M 2024-12



Alnylam Pharmaceuticals - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.